Exploring the role of LOX family in glioma progression and immune modulation
The LOX family is overexpressed in glioma and is associated with poor prognosis and altered immune infiltration patterns. These findings highlight the LOX family as a promising prognostic marker and therapeutic target, particularly for enhancing the effectiveness of immunotherapy in glioma treatment.
Authors
- Hengheng Zhang (ORCID: https://orcid.org/0000-0001-5872-5985)
- Xiaolong Hu (ORCID: https://orcid.org/0000-0003-3450-3733)
- Huilian Qiao (ORCID: https://orcid.org/0000-0003-3163-2134)
- Maohui Yan (ORCID: https://orcid.org/0000-0002-5106-3533)
- Chen Liu (ORCID: https://orcid.org/0000-0001-8155-773X)
- Yingjie Wang (ORCID: https://orcid.org/0000-0003-1005-7900)
- Nan Du (ORCID: https://orcid.org/0000-0003-0496-3392)
- Hongqi Li (ORCID: https://orcid.org/0000-0002-8648-3634)
- Zhiguang Fu (ORCID: https://orcid.org/0000-0002-1916-7447)
Institutions
- Chinese PLA General Hospital (CN)
- Beijing Geriatric Hospital (CN)
- 307th Hospital of Chinese People’s Liberation Army (CN)
- Chinese People's Liberation Army (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-09
- DOI
- https://doi.org/10.3389/fimmu.2025.1512186
- Citations
- 4
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 3.37